Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glutamate Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01420952
What this trial is testing

Imaging of Brain Receptors Using (11C)mGlu1

Who this might be right for
DosimetryPharmacokinetics
National Institute of Mental Health (NIMH) 3
Early research (Phase 1)Study completedNCT00538798
What this trial is testing

PET Imaging of Brain mGluR5 Receptors Using [18F]SP203

Who this might be right for
HealthyGlutamate ReceptormGlur5 Protein+3 more
National Institute of Mental Health (NIMH) 50
Early research (Phase 1)Study completedNCT01548703
What this trial is testing

A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers

Who this might be right for
Healthy
BrainCells Inc. 30
Early research (Phase 1)Study completedNCT01551329
What this trial is testing

Ketamine for Depression and Alcohol Dependence

Who this might be right for
DepressionAlcohol Dependence
Yale University 5
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Early research (Phase 1)Study completedNCT01896843
What this trial is testing

Evaluation of Two Radioactive Chemicals to Image mGluR5 Receptors in Brain

Who this might be right for
mGluR5 Receptors
National Institute of Mental Health (NIMH) 19
Post-approval studies (Phase 4)WithdrawnNCT02028026
What this trial is testing

The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives

Who this might be right for
Major Depressive DisorderAnxietyComorbidity
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT03051256
What this trial is testing

Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD

Who this might be right for
Depressive Disorder, MajorDepressive Disorder, Treatment-Resistant
Relmada Therapeutics, Inc. 62
Post-approval studies (Phase 4)Study completedNCT00688324
What this trial is testing

Biomarker Study of Acamprosate in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Maryland, Baltimore 36
Large-scale testing (Phase 3)UnknownNCT00069550
What this trial is testing

Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome

Who this might be right for
Rett Syndrome
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 90
Not applicableStudy completedNCT02456168
What this trial is testing

Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Northwell Health 30
Early research (Phase 1)Study completedNCT02286817
What this trial is testing

Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder

Who this might be right for
Attention-deficit Hyperactivity Disorder (ADHD)
Aevi Genomic Medicine, LLC, a Cerecor company 30
Not applicableStudy completedNCT00980408
What this trial is testing

The Influence of Glutamate on Memory in Humans

Who this might be right for
Healthy Individuals
University Hospital, Bonn 120
Post-approval studies (Phase 4)Looking for participantsNCT07076342
What this trial is testing

The Role of mGluR5 in CBT-I

Who this might be right for
Major Depressive Disorder (MDD)
Stony Brook University 42
Large-scale testing (Phase 3)Study completedNCT02777931
What this trial is testing

Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Aevi Genomic Medicine, LLC, a Cerecor company 101
Large-scale testing (Phase 3)Looking for participantsNCT07766655
What this trial is testing

Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)

Who this might be right for
Smoking Cessation
Axsome Therapeutics, Inc. 705
Not applicableUnknownNCT02512146
What this trial is testing

The Expression of the Ionotropic Glutamate Receptors in Colon of IBS

Who this might be right for
Irritable Bowel Syndrome
Shandong University 80
Not applicableStudy completedNCT01304147
What this trial is testing

Intranasal Ketamine in Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
James Murrough 20
Not applicableEnded earlyNCT00951314
What this trial is testing

Brain Glutamate Receptors and Cocaine Dependence

Who this might be right for
Drug AbuseCocaine Dependence
National Institute on Drug Abuse (NIDA) 30
Early research (Phase 1)Study completedNCT01359852
What this trial is testing

[11C]JNJ-42491293, a Possible PET Ligand for the mGlu2 Receptor, in Healthy Adult Volunteers

Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20
Next Page